POPE was a multinational, multicentre, prospective, observational, non-interventional registry of patients with chronic obstructive pulmonary disease (COPD) in Central and Eastern Europe. The aim of the POPE study was to assess the distribution of patients with COPD in clinical practice within the CEE region according to disease severity, disease category, and phenotypes.
Primary objective of the project:
- to determine the proportions of patients according to disease severity (stage 1, 2, 3, 4) and risk classification category (A, B, C, D) as defined in the GOLD 2011 strategy; this was carried out in an unselected group of consecutively examined COPD patients in the CEE region.
Secondary objectives of the project:
- to evaluate prevalence rates of various disease phenotypes according to predefined criteria,
- to evaluate diagnostic approaches to COPD in CEE countries,
- to assess the differences in therapeutic approaches in CEE countries.
Other important information:
- Expert guarantors: the POPE study was guaranteed by a steering committee of the project (you can find more detailed information on the website of the POPE project)
- Funding: Boehringer Ingelheim RCV GmbH & Co KG
- Partners: dozens of pulmonology facilities in eleven countries in Central and Eastern Europe (you can find more detailed information on the website of the POPE project)